Now introducing: EmVenio Clinical Research

Welcome to EmVenio Clinical Research – the next era of PCM Trials, EmVenio Research and Clinical Trial Service.

Our new visual identity is now authentically us: warm, welcoming, and human-centered. We’re excited to introduce our new brand – and share the journey that brought us here.

How did we get here?

PCM Trials was founded in 2008 with a clear goal: to make clinical trial participation more accessible for patients, helping bring more therapies to the people who need them all over the world. With the introduction of Certified Mobile Research Nurses (CMRNs), PCM Trials quickly established itself as a trusted leader in home-based clinical trial services.

In 2024, PCM Trials took a major step toward expanding global access to clinical research by acquiring Clinical Trial Service, a Netherlands-based company equally committed to reaching patients wherever they are. Shortly after, PCM Trials acquired EmVenio Research, further strengthening its ability to bring clinical trials directly into local communities through EmVenio’s network of community-based research sites. In addition to its community-based sites, EmVenio also established a network of brick-and-mortar research centers within existing hospital systems, including the Prime Healthcare network. Each location was thoughtfully selected with local social determinants of health in mind – helping remove barriers to participation and enroll populations that others miss.

Since then, PCM Trials, EmVenio Research, and Clinical Trial Service have combined their unique strengths to build a global clinical research organization that meets patients where they are — in their homes, communities, and places they gather. Together, we've expanded access through mobile visits, community-based research sites, and hospital-embedded locations, making trial participation easier and more inclusive.

To reflect this shared mission and unified approach, we made the joint decision to align our services under one name: EmVenio Clinical Research.

Why EmVenio?

The name EmVenio reflects the shared mission, purpose, and values of PCM Trials, EmVenio Research, and Clinical Trial Service. We began with the word “empower”, because our goal is to empower communities by creating more opportunities for research participation and building trust that keeps patients engaged. We then added “venio,” the Latin word meaning “to reach.” This reflects our mission to extend the reach of clinical research by meeting patients where they are and removing barriers to access through flexible participation options, especially for underserved and underrepresented populations.

Together, ”EmVenio” represents who we are: an organization that empowers and reaches patients where they are, removes barriers to participation, and fosters trust and connection throughout the research journey.

Results for you. Science for all.

While our commitment to providing excellent service for our partners remains unchanged, our visual identity has evolved to better reflect who we are and what we stand for. Through warm tones like maroon and amber, we’re breathing new life into space that’s often seen as cold and clinical. This isn’t just a design update – it’s a reflection of our belief that science should feel human, inclusive, and alive. Our updated photography highlights what truly makes clinical research possible: the people. From those who participate in trials to the clinicians, researchers, and principal investigators who conduct them, every breakthrough begins with human connection. Our work wouldn’t be possible without their dedication – and without you.

Our new symbol represents the union of three organizations – PCM Trials, EmVenio, and CTS. Each of its three sides reflects the unified foundation for our shared mission. The shape also resembles a multiplication sign, symbolizing our belief that, together, we can multiply what’s possible in clinical research.

Medical breakthroughs don’t happen by chance – they take time, people, commitment and a determination to go further than before to transform patient outcomes for generations. At EmVenio, we go where others don’t, delivering results for you and science for all.

Our research capabilities span more than 80 countries, allowing us to continually enroll populations that others miss to create a more complete picture for scientific advancement. We deliver clear, reliable data for every project we take on and tailor our research approach to each therapeutic area, successfully enrolling patients from routine to complex populations. From our first conversation, we collaborate closely with partners to  understand their goals, constraints, and needs – whatever they may be\. Our goal is to build lasting relationships rooted in trust and empathy, with a deep understanding of both our partners and the patients they serve.

We recognize the humanity behind every data point, allowing us to maintain industry-leading retention rates and deliver the insights our partners rely on. Because the only way to unlock scientific potential for all is to access patient populations to reflect the real world, deliver expertise at every stage, and foster genuine human connection.